Published in Biomed Pept Proteins Nucleic Acids on January 01, 1995
Redesigned and chemically-modified hammerhead ribozymes with improved activity and serum stability. BMC Chem Biol (2004) 0.81
Radiolabeled oligonucleotides for antisense imaging. Curr Org Synth (2011) 0.78
[Metabolic products of microorganisms. 98. Phosphinothricin and phosphinothricyl-alanyl-analine]. Helv Chim Acta (1972) 2.99
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch (2001) 2.73
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol (2004) 2.70
Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene (2006) 2.36
Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol (1994) 1.78
Culture and characteristics of hormone-responsive neuroblastoma X glioma hybrid cells. Methods Enzymol (1985) 1.70
Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene (2000) 1.69
Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders. Gastroenterology (1990) 1.60
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res (1996) 1.59
DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene (2000) 1.56
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene (2006) 1.55
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene (2001) 1.46
Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res (2001) 1.44
Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer (1994) 1.39
Insolubilized biotin for the purification of avidin. Methods Enzymol (1974) 1.36
Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res (1997) 1.36
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene (2009) 1.32
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol (2007) 1.32
Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res (1998) 1.28
Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology (2004) 1.28
Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells. Br J Cancer (2003) 1.24
Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat (2001) 1.23
The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer (1996) 1.21
The Fas-induced apoptosis analyzed by high throughput proteome analysis. J Biol Chem (2000) 1.20
Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells. Proc Natl Acad Sci U S A (1993) 1.20
Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis. Int J Oncol (1998) 1.18
DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene (1999) 1.13
[13C-NMR chemical shifts of amino acids and peptides]. Z Naturforsch B (1971) 1.13
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer (2004) 1.11
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene (2001) 1.10
FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. J Cell Sci (2001) 1.10
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer (2011) 1.07
Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology (1996) 1.05
Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg (1998) 1.04
Separation of amino acids by high performance liquid chromatography. Anal Chem (1976) 1.02
Various factors influencing the signal intensity of oligonucleotides in electrospray mass spectrometry. Biol Mass Spectrom (1994) 1.02
In vivo studies on the incorporation of microinjected acidic proteins of the large ribosomal subunit from Escherichia coli and artermia salina into oocyte ribosomes from Xenopus laevis. Biochemistry (1979) 1.00
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Oncogene (2007) 0.99
Monoclonal antibody defines CA 19-9 in pancreatic juices and sera. Gut (1985) 0.98
Enantiomer labelling, a method for the quantitative analysis of amino acids. J Chromatogr (1978) 0.97
Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch (2001) 0.96
Characterization of CA 19-9 bearing mucins as physiological exocrine pancreatic secretion products. Cancer Res (1986) 0.96
Autocrine stimulation of human pancreatic duct-like development by soluble isoforms of epimorphin in vitro. J Cell Biol (2001) 0.96
Failure sequences in the solid phase synthesis of polypeptides. J Am Chem Soc (1970) 0.95
Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation. Cell Death Differ (2010) 0.95
Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen. J Cancer Res Clin Oncol (2002) 0.94
Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines. Pancreas (1988) 0.93
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells. Br J Cancer (2006) 0.93
Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor. Clin Cancer Res (1999) 0.93
Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model. Ann Thorac Surg (2001) 0.92
[Studies on the structure of ferredoxin]. Eur J Biochem (1969) 0.92
Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases. World J Gastroenterol (2001) 0.92
A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc Natl Acad Sci U S A (1996) 0.91
Overexpression of p53 protein during pancreatitis. Br J Cancer (1997) 0.91
Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res (1985) 0.90
A new support for polypeptide synthesis in columns. Tetrahedron Lett (1970) 0.89
On-line coupling of capillary electrochromatography, capillary electrophoresis, and capillary HPLC with nuclear magnetic resonance spectroscopy. Anal Chem (1998) 0.89
Evidence from inhibitor studies for conformational changes of citrate synthase. Eur J Biochem (1981) 0.89
Rapid gas chromatographic separation of amino acid enantiomers with a novel chiral stationary phase. J Chromatogr Sci (1977) 0.89
Intact tissue of gastrointestinal cancer specimen orthotopically transplanted into nude mice. Hepatogastroenterology (1999) 0.88
Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model. Int J Cancer (2001) 0.88
Ribosomal protein S6 from Xenopus laevis ovaries. Isolation, phosphorylation in vivo and cross-reaction with heterologous anti-S6 antibodies. Eur J Biochem (1982) 0.88
The TNF family member APRIL promotes colorectal tumorigenesis. Cell Death Differ (2012) 0.88
DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease. Pancreas (1988) 0.87
Transcription of cloned Moloney murine leukemia proviral DNA injected into Xenopus laevis oocytes. Nucleic Acids Res (1983) 0.87
Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A. J Surg Oncol (1997) 0.87
The phosphorylation of ribosomal protein S6 from progesterone-stimulated Xenopus laevis oocytes. Kinetic studies and phosphopeptide analysis. Eur J Biochem (1983) 0.87
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma. Br J Cancer (2008) 0.86
Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma. Cancer Res (1998) 0.86
Immunological escape mechanisms in pancreatic carcinoma. Ann N Y Acad Sci (1999) 0.86
[Degradation and resynthesis of the active sites of plant ferredoxins]. Biochim Biophys Acta (1967) 0.86
Recent advances in capillary electrophoresis/electrospray-mass spectrometry. Electrophoresis (2001) 0.85
Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues. J Nat Prod (2000) 0.85
Combretastatin A-4 prodrug: a potent inhibitor of malignant hemangioendothelioma cell proliferation. Int J Cancer (2000) 0.85
Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg (1999) 0.84
[Synthesis of the C-terminal hexapeptide amide of secretin on a new solid support]. Hoppe Seylers Z Physiol Chem (1971) 0.84
Regulation of T-cell death-associated gene 51 (TDAG51) expression in human T-cells. Cell Death Differ (2004) 0.84
TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression. Int J Oncol (1999) 0.84
Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer. Br J Cancer (2013) 0.84
Hollow-spheres: a new model for analyses of differentiation of pancreatic duct epithelial cells. Ann N Y Acad Sci (1999) 0.83
[Conformation studies on oligoalanines, substance P, and the myoglobin sequence (66-73). Circular dichroism of polyethyleneglycol-bound peptides]. Biopolymers (1976) 0.83
ESR studies of model complexes for non-heme iron proteins. Angew Chem Int Ed Engl (1967) 0.83
Interaction of chemically modified antisense oligonucleotides with sense DNA: a label-free interaction study with reflectometric interference spectroscopy. Anal Chem (1999) 0.83
Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance. Drug Metab Dispos (1997) 0.83
Subcellular transport and ribosomal incorporation of microinjected protein S6 in oocytes from Xenopus laevis. Biochemistry (1982) 0.83
Characterisation and some possible uses of Plukenetia conophora and Adenopus breviflorus seeds and seed oils. Bioresour Technol (2002) 0.83
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients. Eur Urol (2001) 0.83
Preparation of iron-free active xanthine oxidase. Biochim Biophys Acta (1966) 0.82
Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas. Diagn Mol Pathol (1997) 0.82
Recognition of enantiomers by Chirasil-Val and oligopeptide analogues as studied by gas-phase calorimetry and 1H NMR spectroscopy in solution. J Chromatogr (1993) 0.82
Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression. Langenbecks Arch Surg (2005) 0.82
[Intraocular pressure in snorkling and diving (author's transl)]. Klin Monbl Augenheilkd (1976) 0.82
Detection of the anti-p53 antibody response in malignant and benign pancreatic disease. Br J Cancer (1994) 0.82
Analysis of double-stranded oligonucleotides by electrospray mass spectrometry. Anal Chem (1994) 0.82
Synthetic hemopolymers for reversible binding of molecular oxygen. Angew Chem Int Ed Engl (1977) 0.82
An improved orthotopic xenotransplant procedure for human lung cancer in SCID bg mice. Ann Thorac Surg (2000) 0.82
Biglycan gene expression in the human leiomyosarcoma cell line SK-UT-1. Basal and protein kinase A-induced transcription involves binding of Sp1-like/Sp3 proteins in the proximal promoter region. J Biol Chem (1998) 0.81
Styrene metabolism in man: gas chromatographic separation of mandelic acid enantiomers in the urine of exposed persons. Arch Toxicol (1984) 0.81